These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2135009)

  • 1. Cerebral effects of long-term oral opioids in cancer patients measured by continuous reaction time.
    Banning A; Sjøgren P
    Clin J Pain; 1990 Jun; 6(2):91-5. PubMed ID: 2135009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral ketamine and transdermal nitroglycerin as analgesic adjuvants to oral morphine therapy for cancer pain management.
    Lauretti GR; Lima IC; Reis MP; Prado WA; Pereira NL
    Anesthesiology; 1999 Jun; 90(6):1528-33. PubMed ID: 10360847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous reaction time after single dose, long-term oral and epidural opioid administration.
    Sjøgren P; Banning AM; Christensen CB; Pedersen O
    Eur J Anaesthesiol; 1994 Mar; 11(2):95-100. PubMed ID: 8174541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous versus subcutaneous morphine titration in patients with persisting exacerbation of cancer pain.
    Elsner F; Radbruch L; Loick G; Gaertner J; Sabatowski R
    J Palliat Med; 2005 Aug; 8(4):743-50. PubMed ID: 16128648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of long-term opioid therapy on psychomotor function in patients with cancer pain or non-malignant pain].
    Larsen B; Otto H; Dorscheid E; Larsen R
    Anaesthesist; 1999 Sep; 48(9):613-24. PubMed ID: 10525594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management.
    Mercadante S; Porzio G; Ferrera P; Fulfaro F; Aielli F; Verna L; Villari P; Ficorella C; Gebbia V; Riina S; Casuccio A; Mangione S
    Eur J Pain; 2008 Nov; 12(8):1040-6. PubMed ID: 18353696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective study of long-term intrathecal morphine in the management of chronic nonmalignant pain.
    Anderson VC; Burchiel KJ
    Neurosurgery; 1999 Feb; 44(2):289-300; discussion 300-1. PubMed ID: 9932882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful use of methadone in nociceptive cancer pain unresponsive to morphine.
    Leng G; Finnegan MJ
    Palliat Med; 1994; 8(2):153-5. PubMed ID: 7521715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose tramadol in comparison to low-dose morphine for cancer pain relief.
    Grond S; Radbruch L; Meuser T; Loick G; Sabatowski R; Lehmann KA
    J Pain Symptom Manage; 1999 Sep; 18(3):174-9. PubMed ID: 10517038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Continuous epidural morphine administration in long-term analgesic therapy of tumor patients].
    Embey-Isztin D
    Orv Hetil; 1986 Sep; 127(38):2295-8. PubMed ID: 2430249
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparative efficacy and safety of controlled-release morphine suppositories and tablets in cancer pain.
    Babul N; Provencher L; Laberge F; Harsanyi Z; Moulin D
    J Clin Pharmacol; 1998 Jan; 38(1):74-81. PubMed ID: 9597563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid titration with intravenous morphine for severe cancer pain and immediate oral conversion.
    Mercadante S; Villari P; Ferrera P; Casuccio A; Fulfaro F
    Cancer; 2002 Jul; 95(1):203-8. PubMed ID: 12115334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Need of risk reevaluation in morphine dependence in pain patients].
    Boureau F; Luu M; Koskas-Sergent AS; Doubrere JF
    Therapie; 1992 Nov; 47(6):513-8. PubMed ID: 1363796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term cancer pain management in morphine pre-treated and opioid naive patients with transdermal fentanyl.
    Mystakidou K; Tsilika E; Parpa E; Kouloulias V; Kouvaris I; Georgaki S; Vlahos L
    Int J Cancer; 2003 Nov; 107(3):486-92. PubMed ID: 14506751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The 118 A > G polymorphism in the human mu-opioid receptor gene may increase morphine requirements in patients with pain caused by malignant disease.
    Klepstad P; Rakvåg TT; Kaasa S; Holthe M; Dale O; Borchgrevink PC; Baar C; Vikan T; Krokan HE; Skorpen F
    Acta Anaesthesiol Scand; 2004 Nov; 48(10):1232-9. PubMed ID: 15504181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective study evaluating the response of patients with unrelieved cancer pain to parenteral opioids.
    Enting RH; Oldenmenger WH; van der Rijt CC; Wilms EB; Elfrink EJ; Elswijk I; Sillevis Smitt PA
    Cancer; 2002 Jun; 94(11):3049-56. PubMed ID: 12115396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical efficacy, safety and pharmacokinetics of a newly developed controlled release morphine sulphate suppository in patients with cancer pain.
    Moolenaar F; Meijler WJ; Frijlink HW; Visser J; Proost JH
    Eur J Clin Pharmacol; 2000 Jun; 56(3):219-23. PubMed ID: 10952476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pain, sedation and reaction time during long-term treatment of cancer patients with oral and epidural opioids.
    Sjøgren P; Banning A
    Pain; 1989 Oct; 39(1):5-11. PubMed ID: 2812854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Constant infusion of morphine for intractable cancer pain using an implanted pump.
    Hassenbusch SJ; Pillay PK; Magdinec M; Currie K; Bay JW; Covington EC; Tomaszewski MZ
    J Neurosurg; 1990 Sep; 73(3):405-9. PubMed ID: 2384779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracerebroventricular administration of morphine for control of irreducible cancer pain.
    Lazorthes YR; Sallerin BA; Verdié JC
    Neurosurgery; 1995 Sep; 37(3):422-8; discussion 428-9. PubMed ID: 7501106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.